Next month, Reed Smith will host a pharmaceutical, medical device and life sciences antitrust seminar, featuring a keynote address and question and answer session with Richard Feinstein , director of the Federal Trade Commission ‘s bureau of competition.
Three panel discussions will follow with attorneys, economists from NERA Economic Consulting and representatives from pharmaceutical companies addressing “Discount Programs and Free Samples: Making Sure Your Good Deeds Go Unpunished,” “Use and Misuse of Competitive Intelligence” and “Responding to Search Warrants and Dawn Raids.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
